Skip to main content

Louisiana, A New Entrant Joins The Opioid MDL

Louisiana, A New Entrant Joins The Opioid MDL

Louisiana, A New Entrant Joins The Opioid MDL

Introduction

Louisiana is now putting efforts to redirect all the lawsuits against opioid manufacturers into the MDL to join more than 2,000 other lawsuits from states, cities, and school districts.

According to Jacques Ambers, special assistant to Louisiana Attorney General Jeff Landry, Landry was working collaboratively with the governor’s office against the opioid crisis but now will redirect his efforts into the MDL.

The state saw a rise in opioid overdoses, and the Louisiana Department of Health reported that there have been 401 deaths statewide in 2017, a rise from 217 in 2014. The crisis drained nearly $300 million from state coffers annually, which was used for incarceration, social services, health care, schools, and lost productivity.  

Last month, plaintiffs filed a motion seeking certification for a negotiation class, a new structure that will be representing all 24,500 cities and counties in the U.S. as part of an opioid settlement.

U.S. District Judge Dan Polster is presiding over all opioid lawsuits consolidated under MDL No. 2804 (In Re: National Prescription Opiate Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!